Axogen Inc. (AXGN): Share Price, Stock Analysis, Annual Report | Value Research Get Axogen Inc. (AXGN)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Medical Devices & Equipment

Axogen Inc. (AXGN)

NASDAQ: AXGN

  • Market Capitalisation info

    $472 Mln


  • 12 Month Earnings info

    $-32 Mln

  • Price to Earnings info

    --

$10.90

As on 17-Aug-2022 13:31 EDT

up-down-arrow $-0.28-2.50%

  • Prev Close info

    $11.18

  • Day's Openinfo

    $11.04

  • Today's Highinfo

    $11.12

  • Today's Lowinfo

    $10.61

  • Today's Volumeinfo

    93,278

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Axogen (AXGN)
16.33 27.04 13.66 -30.93 -10.73 -6.62 13.40
S&P BSE Sensex
3.44 12.09 13.75 8.42 17.29 13.66 13.06
S&P Small-Cap 600
-8.42 12.89 8.31 -4.42 11.76 8.97 10.87
As on 17-Aug-2022
2021
2020
2019
2018
2017
2016
2015
Axogen (AXGN)
-47.65 0.06 -12.43 -27.68 214.44 80.00 39.28
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Chairman, Pres & CEO

        Ms. Karen Zaderej

        Exec. VP & CFO

        Mr. Peter J. Mariani

        Headquarters

        Alachua, FL
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $471.89 Mln

        • Revenue (TTM) info

          $128.20 Mln

        • Earnings (TTM) info

          $-31.64 Mln

        • Cash info

          $58.03 Mln

        • Total Debt info

          $67.68 Mln

        • Insider's Holding

          4.69%

        • Liquidity info

          Low

        • 52 Week range info

          $6.87 - 17.99

        • Shares outstanding info

          42,283,700

        • 10 Years Aggregate:

          CFO: $-123.82 Mln

          EBITDA: $-137.36 Mln

          Net Profit: $-182.20 Mln

        About The Company

        • Business

          AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves.

        • IPO Date

          27-Mar-1990

        • Chairman, Pres & CEO

          Ms. Karen Zaderej

        • Exec. VP & CFO

          Mr. Peter J. Mariani

        • Listing info

          NASDAQ: AXGN

        • Country

          United States

        • Headquarters info

          Alachua, FL

        • Website info

          https://www.axogeninc.com